FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HUTTON THOMAS C
2. Issuer Name and Ticker or Trading Symbol

CHEMED CORP [ CHE ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
vice president
(Last)          (First)          (Middle)

1270 AVENUE OF THE AMERICAS, SUITE 1905
3. Date of Earliest Transaction (MM/DD/YYYY)

10/29/2019
(Street)

NEW YORK, NY 10020
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
stock option(right to buy with tandem tax withholding)  $413.19  10/29/2019    A     3800       (1) 10/29/2024  capital stock  3800  $413.19  21400  D   

Explanation of Responses:
(1)  Vesting in three equal annual installments commencing 10/29/2020

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HUTTON THOMAS C
1270 AVENUE OF THE AMERICAS
SUITE 1905
NEW YORK, NY 10020
X
vice president

Signatures
Thomas C. Hutton 10/31/2019
**Signature of Reporting Person Date


Chemed (NYSE:CHE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Chemed Charts.
Chemed (NYSE:CHE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Chemed Charts.

Chemed Corp News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Chemed Reports First-Quarter 2024 Results
Wednesday 24 April 2024 (2 days ago) • Business Wire
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
Wednesday 17 April 2024 (1 week ago) • Business Wire
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Monday 1 April 2024 (4 weeks ago) • Business Wire
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
Wednesday 13 March 2024 (1 month ago) • Business Wire
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
Friday 8 March 2024 (2 months ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Chemed Reports Fourth-Quarter 2023 Results
Tuesday 27 February 2024 (2 months ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)